Page 26 - ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covaxin: Bharat Biotech likely to get WHO nod for emergency use listing by July-September

May 25, 2021 Regulatory approvals for Covaxin are in process in more than 60 countries, says Hyderbad-based pharma Hyderabad-based Bharat Biotech is likely to get World Health Organization (WHO) approval for the emergency use listing (EUL) of its vaccine Covaxin between July and September. “Application for EUL has been submitted to WHO-Geneva and regulatory approvals are expected by July-September 2021,” the company announced on Tuesday. It further said that regulatory approvals for Covaxin are in process in more than 60 countries including the US, Brazil and Hungary among others. The company has obtained emergency use authorisation in 13 countries with more to follow. Besides this, Bharat Biotech also said that while most countries are recommending vaccinations against Covid-19, unvaccinated travellers can travel with negative RT-PCR tests before travel, in the absence of any other country-specific travel restrictions.

World health organizationHyderabad based bharat biotechBharat biotechWho nodEmergency useJuly septemberஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக்பாரத் பயோடெக்அவசரம் பயன்பாடுஜூலை செப்டம்பர்

COVID Vaccines: Without WHO Approval, Covaxin Remains Second Among Equals

COVID Vaccines: Without WHO Approval, Covaxin Remains Second Among Equals 25/05/2021 A vial of Covaxin. Photo: DTM/Wikimedia Commons, CC BY-SA 4.0 New Delhi: Last week, the 27 countries in the European Union agreed to ease travel restrictions to non-EU visitors who are fully vaccinated against COVID-19, in a move that could see tourists return to the continent ahead of the summer. This was the first concrete sign that the world is indeed moving towards an era of ‘vaccine passports’ – restrictions against people who haven’t yet been fully vaccinated. For Indians, however, this development may not come as good news, even to those who have been fully vaccinated. Covaxin, the vaccine developed by the Hyderabad-based Bharat Biotech, is not yet on the WHO’s ’emergency use list’ (EUL), nor does it have similar approval from the EU’s European Medicines Agency (EMA).

New delhiWikimedia commonsJammi nagaraj raoNarendra modiJanssen johnsonEu european medicines agencyUniversity of oxfordEuropean unionSerum institute of indiaMinistry of external affairsHyderabad based bharat biotechMedicines agencyMinister narendra modiBharat biotechSerum instituteExternal affairs

Bharat Biotech likely to get WHO nod for emergency use listing of Covaxin

Bharat Biotech likely to get WHO nod for emergency use listing of Covaxin May 25, 2021 The regulatory approvals for Covaxin are expected by July-September 2021 Hyderabad-based Bharat Biotech is likely to get World Health Organization (WHO) approval for the emergency use listing (EUL) of its vaccine Covaxin between July and September. “Application for EUL has been submitted to WHO-Geneva and regulatory approvals are expected by July-September 2021,” the company announced on Tuesday. It further said that regulatory approvals for Covaxin are in process in more than 60 countries including the US, Brazil and Hungary, among others. The company has obtained emergency use authorisation in 13 countries with more to follow.

World health organizationHyderabad based bharat biotechBharat biotechWho approvalEmergency use listing of covaxinWho approval of covaxinஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக்பாரத் பயோடெக்

Bharat Biotech expects WHO nod for Covaxin in Sept quarter

Bharat Biotech expects WHO nod for Covaxin in Sept quarter
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Andhra pradeshNational institute of virologyTechnical advisory groupWorld health organisationHyderabad based bharat biotechWorld healthBharat biotechMaster fileNational instituteஆந்திரா பிரதேஷ்தேசிய நிறுவனம் ஆஃப் வைராலஜிஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக்உலகம் ஆரோக்கியம்பாரத் பயோடெக்தேசிய நிறுவனம்

Bharat Biotech expects WHO nod for Covaxin in Sept quarter

Bharat Biotech expects WHO nod for Covaxin in Sept quarter
origin-businesstoday.intoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from origin-businesstoday.intoday.in Daily Mail and Mail on Sunday newspapers.